5HT3antagonists for prophylaxis of postoperative nausea and vomiting in breast surgery: A meta-analysis
Author(s) -
VS Gota,
AK Singhal,
S. Kannan
Publication year - 2012
Publication title -
journal of postgraduate medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.405
H-Index - 52
eISSN - 0972-2823
pISSN - 0022-3859
DOI - 10.4103/0022-3859.93249
Subject(s) - medicine , jadad scale , placebo , postoperative nausea and vomiting , randomized controlled trial , meta analysis , nausea , adverse effect , odds ratio , vomiting , anesthesia , cochrane library , alternative medicine , pathology
Postoperative nausea and vomiting (PONV) are distressing adverse events following breast cancer surgery with an incidence of up to 80%. 5HT 3 antagonists are commonly employed as drugs of first choice for PONV although there is no clear evidence favoring one pharmacological approach over another.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom